Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Immunodiagnostics Market Expected to Grow Between 2025 And 2029?

The market size of immunodiagnostics has been expanding robustly over the past few years. An upward trajectory from $22.88 billion in 2024 to $24.32 billion in 2025 is projected, exhibiting a compound annual growth rate (CAGR) of 6.3%. Such growth in the historical era is linked to the escalating occurrence of infectious diseases, increased cases of autoimmune diseases, cancer detection and surveillance, the worldwide spread of infectious diseases, public health endeavors, and monitoring initiatives.

In the coming years, the size of the immunodiagnostics market is forecasted to increase significantly. Its value is projected to reach $32.89 billion in 2029, with a compound annual growth rate (CAGR) of 7.8%. The market’s expansion during the forecast period is linked to factors such as preparedness and response to pandemics, personalized medicine, biomarker discovery, improvements in healthcare infrastructure in emerging economies, and integration with laboratory information systems, as well as the increasing prevalence of chronic diseases. Key trends that will shape the market in the forecast period include multiplexing technologies, point-of-care testing (POCT), advances in biomarker discovery and personalized medicine, the emergence of digital immunodiagnostics, and a move towards liquid biopsy.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

What Are the Core Growth Drivers Propelling the Immunodiagnostics Market Forward?

The anticipated rise in infectious diseases is predicted to facilitate the expansion of the immunodiagnostics market. These diseases, precipitated by the transmission of germs such as bacteria, viruses, parasites or fungi, are detectable using an immunodiagnostic assay that recognizes a virus in a blood sample. An increase in tuberculosis cases, reported by a US government agency, the Centers for Disease Control and Prevention, from 8,320 in 2022 to 9,615 in 2023, signifies a rise of 1,295 cases. This growth in infectious diseases thus foretells an upward trend in the immunodiagnostics market.

What Segment Types Define the Immunodiagnostics Market Structure?

The immunodiagnosticsmarket covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments, Software And Services

2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies

3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications

4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Subsegments:

1) By Reagents And Consumables: Antibodies, Assay Kits, Buffers And Substrates

2) By Instruments: Immunoassay Analyzers, Flow Cytometers, ELISA Readers

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10093&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Immunodiagnostics Market?

North America was the largest region in the immunodiagnostics market in 2024. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Emerging Trends that Are Influencing theImmunodiagnostics Industry Evolution?

Key players in the immunodiagnostics market are honing in on developing cutting-edge solutions like the S. pneumoniae antigen immunodiagnostic assay to facilitate the detection of pneumococcal pneumonia infection. This assay is specifically designed to find Streptococcus pneumoniae antigens in body fluids, thereby assisting in diagnosing pneumococcal infections. For example, DiaSorin S.p.A., a biotechnology corporation based in Italy, unveiled the LIAISON S. pneumoniae antigen immunodiagnostic assay in September 2024. This particular diagnostic tool is used for the qualitative detection of Streptococcus pneumoniae antigens in urine samples taken from adults suspected of having pneumococcal pneumonia. It provides a high-throughput solution enabling healthcare professionals to quickly discern pneumococcal pneumonia from other respiratory ailments. The assay, which is built to work on LIAISON CLIA analyzers, yields results within 35 minutes, paving the way for immediate and targeted treatment with antimicrobials. In addition, it can identify 91 serotypes, thereby supporting improved clinical decision making and efficient use of antibiotics, representing a noteworthy advancement in the immunodiagnostics arena for community-acquired pneumonia.

View the full report here:

https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

What Is the Definition of the Immunodiagnostics Market?

Immunodiagnostics refers to a diagnostic methodology that relies primarily on an antigen-antibody response for the detection of serum insulin. Immunodiagnostic tests are used to detect antibodies and parasite antigens.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10093

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model